Live Breaking News & Updates on Corvas International

Stay updated with breaking news from Corvas international. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

2023-09-07 | NDAQ:ONCT | Press Release | Oncternal Therapeutics Inc

(2023-09-07 | NDAQ:ONCT) Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board ....

Santa Monica , United States , City Of , United Kingdom , San Diego , Mecklenburg Vorpommern , Gunnar Kaufmann , Dehm Closecurlyquote , Richard Vincent , James Breitmeyer , Scott Dehm , Corey Davis , Howard Soule , Evan Yu , Oncternal Closecurlyquote , Cancer Research , University Of Washington School Medicine , Glasgow University , Apogee Enterprises , University Of Greifswald , University Of Washington , Prostate Cancer Foundation , Corvas International Inc , Dana Farber Cancer Institute , University Minnesota , American Association For Cancer Research ,

Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board

Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Santa Monica , United States , San Diego , City Of , United Kingdom , Mecklenburg Vorpommern , Howard Soule , Evan Yu , Scott Dehm , James Breitmeyer , Corey Davis , Gunnar Kaufmann , Richard Vincent , Baylor College Of Medicine , American Association For Cancer Research , Corvas International Inc , Department Of Laboratory Medicine , Apogee Enterprises , Drug Development Unit , University Of Greifswald , American Association Of Immunologists , University Of Saskatchewan , Oncternal Therapeutics Inc , Royal College Of Physicians , University Of Washington , Milken Institute ,

Toragen, Inc. Announces Appointment of Chief Scientific Officer

Toragen is focused on uniquely selective drugs targeting cancers caused by the human papillomavirus (“HPV”)SAN DIEGO (BUSINESS WIRE) Toragen, Inc., a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs targeting cancers caused by the human papilloma. ....

Sandra Coufal , Rick Lumpkin , Portola Pharmaceuticals , Corvas International Inc , Toragen Inc , Millennium Pharmaceuticals , San Diego Based , Chief Scientific , Chief Scientific Officer , Global Blood Therapeutics , Corvas International ,

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United States , Richard Lumpkin , Andrew Sharabi , Los Angeles , Cheryl Collett , Anivive Lifesciences , Paul Engler , Sandra Coufal , Corvas International Inc , Toragen Inc , Research Development , Millennium Pharmaceuticals , University Of Missouri , Portola Pharmaceuticals , Virginiaj Engler Foundation , California State University , Board Of Directors The Company , San Diego Based , Puma Biotechnology , Sierra Scientific Instruments , Cougar Biotechnology , Century Fox , Senior Director , Global Blood Therapeutics , Third Rock Ventures , Cor Therapeutics ,

Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno

SUNNYVALE, Calif. (BUSINESS WIRE) #aging Rubedo Life Sciences, a biopharmaceutical company pioneering first-in-class therapies for chronic age-related diseases targeting the senescent cells that drive cellular aging, today announced the appointment of veteran biotech executives Ali Siam as Chief Business Officer. ....

United States , Boston College , Harvard University , Northeastern University , Marco Quarta , Yoshito Kishi , Bayer Ag , Corvas International , Boston Scientific , Cornell University , Rubedo Life Sciences , Founder Of Rubedo Life Sciences , Ali Siam , Chief Business Officer , Ofir Moreno , Senior Vice President , Chief Executive Officer , Rubedo Life , Market Access , Infectious Disease , Mechanical Engineering , Drug Discovery , Pharmaceutical Sciences , Norganic Chemistry , Professor Yoshito Kishi , Life Sciences ,